Lower Back Pain: Clinical Trials

4 trials for Lower Back Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Terminated 1

Follow Lower Back Pain: new trials by email Literature Review of Lower Back Pain trials Research Report on Lower Back Pain

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans
Pregnenolone, Placebo - Lower Back Pain
Phase 2CompletedDurham VA Medical Center942013-09-132018-10-03
Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain
Placebo, AbobotulinumtoxinA Treatment - Lower Back Pain
Phase 2TerminatedYale University432012-12-012016-07-20
Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain
Naltrexone and Clonidine Combination, placebo - Back Pain, Lower Back Pain
Phase 2CompletedAnnette C. Toledano MD782011-07-012021-04-14

Narrower conditions

Low Back Pain (4)  ·  Pain (2)  ·  Back Pain (1)  ·  Neck Pain (1)  ·  Neuralgia (1)  ·  Obesity (1)

Broader conditions

Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Back Pain (3)  ·  Pain (2)  ·  Body Weight (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Peripheral Nervous System Diseases (1)

Interventions

Naltrexone (1)  ·  Pregnenolone (1)  ·  abobotulinumtoxinA (1)  ·  semaglutide (1)

Sponsors

Annette C. Toledano MD (1)  ·  Durham VA Medical Center (1)  ·  Washington University School of Medicine (1)  ·  Yale University (1)

Countries

United States (4)

Top investigators

Annette C Toledano, MD (1)  ·  Bahman Jabbari, MD (1)  ·  Burel R Goodin, PhD (1)  ·  Christine E Marx, MD (1)  ·  Jacob K Greenberg, MD, MSCI (1)  ·  Jennifer C. Naylor, PhD (1)

Results publications

PMID 32119096

NIH funding

1IK2RX000908-01A1 (1)